|
Hayward,
CA | March 21, 2005 Quantum Dot Corporation announces
launch of the Mosaic Gene Expression Assay System.
For the first time, pharmaceutical, biotechnology
and functional genomics researchers can measure quantitative
expression of 100 user-specified mRNAs simultaneously
from small amounts of input sample. The Mosaic System
offers a unique combination of features, including:
Custom
multiplex of 100 user-specified genes; 200 genes will
be available later in 2005
Calibrators
and assay quality controls built into every assay
Exceptional technical performance
Sensitivity comparable to qPCR with better precision
Measure less than 1.4-fold changes in mRNA expression
High throughput for large projects: 360 samples
of 100 genes per sample in 24 hours
“The
combination of quality controls in every assay, exceptional
performance, throughput and project cost savings brings
tremendous benefit to researchers and a better way
to implement gene expression analysis for discovery,
compound screening and lead validation,” cites Senior
Marketing Manager, Stephen Chamberlain, Ph.D.
The
Mosaic System includes the Mosaic Q1000 Scanner and
computer, Mosaic software, and custom Gene Panels
configured in convenient kit format; the assay is
designed for automated processing on liquid-handling
workstations. Each custom Gene Panel is designed and
manufactured with gene-specific beads that are spectrally
coded with the QDC’s innovative Qdot® nanocrystals.
Fluorescent spectral codes are identified and gene
data is measured by the Mosaic Q1000 Scanner and analyzed
by the Mosaic Data Collector and Expression Manager
Software modules.
Quantum
Dot CEO, George Dunbar explains, “This cutting edge
technology, combined with QDC’s Qdot nanocrystal expertise,
not only allows scientists to perform fine gene expression
research on the most important subsets of genes for
compound discovery and development, but also satisfies
new demands in emerging fields such as Translational
and Molecular Medicine.”
About
Quantum Dot Corporation
Quantum Dot Corporation (QDC) is a privately held
bioscience company that pioneered the development
and commercialization of Qdot® nanocrystals for
bio-detection in discovery and clinical applications.
QDC’s current products include life-science kits and
applications used by academic and pharmaceutical-discovery
laboratories worldwide. In addition, QDC recently
launched its first integrated instrumentation, software,
and bio-reagents platform, the Mosaic™ System, for
rapid and quantitative multiplexed gene expression
analysis. QDC collaborates with leading academic and
industrial partners and has over 150 patents and patentspending.
For more information, visit www.qdots.com.
Contact:
George Dunbar
CEO, Quantum Dot Corporation
(510) 887 8775, ext. 4101
Gayle
Kuokka
CFO, Quantum Dot Corporation
(510) 887 8775, ext. 4199
Copyright
© Quantum Dot Corporation
|
